Eric Shinohara, MD, MSCI, discusses the potential to combine stereotactic body radiotherapy with immunotherapy in prostate cancer.
Eric Shinohara, MD, MSCI
Advertisement
Articles by Eric Shinohara, MD, MSCI
Eric Shinohara, MD, MSCI, discusses radiation therapy considerations for patients with prostate cancer.
Eric Shinohara, MD, MSCI, discusses the toxicities associated with stereotactic body radiotherapy in prostate cancer.
Eric Shinohara, MD, MSCI, discusses the future of stereotactic body radiation and surgery in prostate cancer.
Eric Shinohara, MD, MSCI, discusses the emergence of stereotactic body radiotherapy to treat patients with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Shinohara on Stereotactic Body Radiotherapy to Treat Prostate CancerNovember 25th 2019
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
NMPA Accepts Toripalimab Plus Chemotherapy Application for Expanded Stage II-III NSCLC Use
3
Ivonescimab Plus Chemotherapy Sustains OS Benefit Across Western and Asian Patients in Pretreated EGFR-Mutated NSCLC
4
Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer
5